ℹ️
🇬🇧
Search
Search for people relevant for "Ibrutinib"
Ibrutinib
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Martin Šimkovič Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
90 publications
Publications
publication
Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group
2020 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
2019 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Single-agent ibrutinib in RESONATE-2TM and RESONATETM versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia
2019 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Treatment of repeatedly relapsing chronic lymphocytic leukemia
2018 |
Faculty of Medicine in Hradec Králové
publication
Treatment of elderly and comorbid patients with chronic lymphocytic leukemia
2017 |
Faculty of Medicine in Hradec Králové
publication
Practical approach to management of chronic lymphocytic leukemia
2016 |
Faculty of Medicine in Hradec Králové
publication
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine
publication
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
2023 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Pulmonary damage in a patient with hairy cell leukemia - infectious involvement or hematological disease activity? Case report
2023 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
Load more publications (80)
Loading network view...